Lactobacillus plantarum LP-LDL is a probiotic identified using a systematic discovery process. Its efficacy in lowering cholesterol and systolic blood pressure has been demonstrated in three published human studies. The results of these studies will be presented. The use of pharmaceutical type discovery platforms to screen large numbers of probiotics for a mechanism of action and improvements in established clinical biomarkers for a health condition narrows the gap between supplements and pharmaceutical products.
Get the presentation in seconds. Fill in the form opposite.
The Kidlington Centre
Oxford, OX5 2DL
+44 1865 849 841